Prevalence of High and Low Level Mupirocin Resistance among Staphylococcal Isolates from Skin Infection in a Tertiary Care Hospital
Author(s) -
S. Jayakumar,
M Meerabai,
Shameem Banu A S,
Renu Mathew,
M Kalyani,
Binesh Lal Y
Publication year - 2013
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2013/4694.2736
Subject(s) - mupirocin , staphylococcus aureus , staphylococcus , microbiology and biotechnology , medicine , staphylococcus haemolyticus , methicillin resistant staphylococcus aureus , coagulase , staphylococcal infections , antibiotics , micrococcaceae , antibacterial agent , biology , bacteria , genetics
Mupirocin has been used for the treatment of skin infections and for the eradication of the nasal carriage of Methicillin -resistant Staphylococcus aureus (MRSA). The increased use of this antibiotic has been accompanied by its resistance, resulting in treatment failures.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom